244 related articles for article (PubMed ID: 30305424)
21. Identifying the SUMO1 modification of FAM122A leading to the degradation of PP2A-Cα by ubiquitin-proteasome system.
Fan F; Zhao J; Liu Y; Zhao H; Weng L; Li Q; Chen G; Xu Y
Biochem Biophys Res Commun; 2018 Jun; 500(3):676-681. PubMed ID: 29678583
[TBL] [Abstract][Full Text] [Related]
22. The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.
Ohbayashi N; Kawakami S; Muromoto R; Togi S; Ikeda O; Kamitani S; Sekine Y; Honjoh T; Matsuda T
Biochem Biophys Res Commun; 2008 Jul; 371(4):823-8. PubMed ID: 18474224
[TBL] [Abstract][Full Text] [Related]
23. SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans.
Dai XQ; Plummer G; Casimir M; Kang Y; Hajmrle C; Gaisano HY; Manning Fox JE; MacDonald PE
Diabetes; 2011 Mar; 60(3):838-47. PubMed ID: 21266332
[TBL] [Abstract][Full Text] [Related]
24. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
[TBL] [Abstract][Full Text] [Related]
25. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.
Sun XX; He X; Yin L; Komada M; Sears RC; Dai MS
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3734-9. PubMed ID: 25775507
[TBL] [Abstract][Full Text] [Related]
26. Regulation of post-translational modification in breast cancer treatment.
Heo KS
BMB Rep; 2019 Feb; 52(2):113-118. PubMed ID: 30638182
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma.
Guo J; Lv Y; Wang S; Peng Z; Xie Y; Wang Y; Jiang H; Li X; Wang M; Hu M; Mu J; Wang J; Xie Y; Cheng X; Zhao Z; Liu Z
Oncogene; 2022 Nov; 41(45):4971-4979. PubMed ID: 36209257
[TBL] [Abstract][Full Text] [Related]
28. MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.
Lemma RB; Ledsaak M; Fuglerud BM; Rodríguez-Castañeda F; Eskeland R; Gabrielsen OS
J Biol Chem; 2023 Sep; 299(9):105062. PubMed ID: 37468105
[TBL] [Abstract][Full Text] [Related]
29. Exploring the desumoylation process of SENP1: a study combined MD simulations with QM/MM calculations on SENP1-SUMO1-RanGAP1.
Shi T; Han Y; Li W; Zhao Y; Liu Y; Huang Z; Lu S; Zhang J
J Chem Inf Model; 2013 Sep; 53(9):2360-8. PubMed ID: 23930863
[TBL] [Abstract][Full Text] [Related]
30. Noncovalent binding of small ubiquitin-related modifier (SUMO) protease to SUMO is necessary for enzymatic activities and cell growth.
Ihara M; Koyama H; Uchimura Y; Saitoh H; Kikuchi A
J Biol Chem; 2007 Jun; 282(22):16465-75. PubMed ID: 17428805
[TBL] [Abstract][Full Text] [Related]
31. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.
Hajmrle C; Ferdaoussi M; Plummer G; Spigelman AF; Lai K; Manning Fox JE; MacDonald PE
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E664-73. PubMed ID: 25139051
[TBL] [Abstract][Full Text] [Related]
32. Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
Abdel-Hafiz HA; Horwitz KB
BMC Mol Biol; 2012 Mar; 13():10. PubMed ID: 22439847
[TBL] [Abstract][Full Text] [Related]
33. Binding to small ubiquitin-like modifier and the nucleolar protein Csm1 regulates substrate specificity of the Ulp2 protease.
de Albuquerque CP; Suhandynata RT; Carlson CR; Yuan WT; Zhou H
J Biol Chem; 2018 Aug; 293(31):12105-12119. PubMed ID: 29903909
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the tumor suppressor PTEN by SUMO.
González-Santamaría J; Campagna M; Ortega-Molina A; Marcos-Villar L; de la Cruz-Herrera CF; González D; Gallego P; Lopitz-Otsoa F; Esteban M; Rodríguez MS; Serrano M; Rivas C
Cell Death Dis; 2012 Sep; 3(9):e393. PubMed ID: 23013792
[TBL] [Abstract][Full Text] [Related]
35. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
[TBL] [Abstract][Full Text] [Related]
36. Noncovalent structure of SENP1 in complex with SUMO2.
Ambaye ND
Acta Crystallogr F Struct Biol Commun; 2019 May; 75(Pt 5):332-339. PubMed ID: 31045562
[TBL] [Abstract][Full Text] [Related]
37. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.
Cheng J; Kang X; Zhang S; Yeh ET
Cell; 2007 Nov; 131(3):584-95. PubMed ID: 17981124
[TBL] [Abstract][Full Text] [Related]
38. Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression.
Li X; Lee YK; Jeng JC; Yen Y; Schultz DC; Shih HM; Ann DK
J Biol Chem; 2007 Dec; 282(50):36177-89. PubMed ID: 17942393
[TBL] [Abstract][Full Text] [Related]
39. SUMOylation regulates AKT1 activity.
de la Cruz-Herrera CF; Campagna M; Lang V; del Carmen González-Santamaría J; Marcos-Villar L; Rodríguez MS; Vidal A; Collado M; Rivas C
Oncogene; 2015 Mar; 34(11):1442-50. PubMed ID: 24704831
[TBL] [Abstract][Full Text] [Related]
40. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
